Ligand Based Drug Design of Novel Aldose Reductase Inhibitors Based Off β-Glucogallin: A Major Active Component from E. officinalis, A Traditional Ayurvedic Botanical

被引：0

|

作者：

Li, L. ^{[1
]}

Chang, K. C. ^{[2
]}

Ponder, J. ^{[1
]}

Zhou, Y. ^{[1
]}

Ali, H. ^{[1
]}

Adedoyin, A. ^{[1
]}

Shieh, B. ^{[1
]}

Petrash, J. M. ^{[2
]}

LaBarbera, D., V ^{[1
]}

机构：

[1] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO 80045 USA

[2] Univ Colorado, Dept Ophthalmol, Aurora, CO 80045 USA

来源：

PLANTA MEDICA | 2013年 / 79卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q94 [植物学];

学科分类号：

071001 ;

摘要：

PC3

引用

收藏

页码：827 / 827

页数：1

相关论文

共 3 条

[1] β-glucogallin: A novel aldose reductase inhibitor from E. officinalis used in traditional ayurveda to treat diabetes
Puppala, M.
Ponder, J.
Suryanarayana, P.
Reddy, G. B.
Petrash, J. M.
LaBarbera, D., V
[J]. PLANTA MEDICA, 2012, 78 (11) : 1185 - 1185
[2] Ligand-based drug design of novel aldose reductase inhibitors
Majekova, Magdalena
[J]. FUTURE MEDICINAL CHEMISTRY, 2018, 10 (21) : 2493 - 2496
[3] Unveiling the potential of novel 5α-reductase inhibitors via ligand based drug design, molecular docking and ADME predictions to manage BPH
Rana, Priyanka
Sharma, Shiwani
Das, Agneesh Pratim
Agarwal, Subhash Mohan
Kaur, Tanzeer
Dhingra, Neelima
[J]. JOURNAL OF MOLECULAR STRUCTURE, 2025, 1320